Demonstration of the usefulness of epigenetic cancer risk prediction by a multicentre prospective cohort study

Background Epigenetic alterations accumulate in normal-appearing tissues of patients with cancer, producing an epigenetic field defect. Cross-sectional studies show that the degree of the defect may be associated with risk in some types of cancer, especially cancers associated with chronic inflammation. Objective To demonstrate, by a multicentre prospective cohort study, that the risk of metachronous gastric cancer after endoscopic resection (ER) can be predicted by assessment of the epigenetic field defect using methylation levels. Design Patients with early gastric cancer, aged 40–80 years, who planned to have, or had undergone, ER, were enrolled at least 6 months after Helicobacter pylori infection discontinued. Methylation levels of three preselected genes (miR-124a-3, EMX1 and NKX6-1) were measured by quantitative methylation-specific PCR. Patients were followed up annually by endoscopy, and the primary endpoint was defined as detection of a metachronous gastric cancer. Authentic metachronous gastric cancers were defined as cancers excluding those detected within 1 year after the enrolment. Results Among 826 patients enrolled, 782 patients had at least one follow-up, with a median follow-up of 2.97 years. Authentic metachronous gastric cancers developed in 66 patients: 29, 16 and 21 patients at 1–2, 2–3 and ≥3 years after the enrolment, respectively. The highest quartile of the miR-124a-3 methylation level had a significant univariate HR (95% CI) (2.17 (1.07 to 4.41); p=0.032) and a multivariate-adjusted HR (2.30 (1.03 to 5.10); p=0.042) of developing authentic metachronous gastric cancers. Similar trends were seen for EMX1 and NKX6-1. Conclusions Assessment of the degree of an epigenetic field defect is a promising cancer risk marker that takes account of life history.

[1]  H. Grabsch,et al.  Gastric Cancer Pathology and Underlying Molecular Mechanisms , 2013, Digestive Surgery.

[2]  M. Esteller,et al.  Novel Methylation Panel for the Early Detection of Neoplasia in High-risk Ulcerative Colitis and Crohn's Colitis Patients , 2013, Inflammatory bowel diseases.

[3]  M. Toyota,et al.  Aberrant Methylation of RASGRF1 Is Associated with an Epigenetic Field Defect and Increased Risk of Gastric Cancer , 2012, Cancer Prevention Research.

[4]  Tsutomu Nishida,et al.  Scheduled endoscopic surveillance controls secondary cancer after curative endoscopic resection for early gastric cancer: a multicentre retrospective cohort study by Osaka University ESD study group , 2012, Gut.

[5]  Nayoung Kim,et al.  Prediction of the risk for gastric cancer using candidate methylation markers in the non‐neoplastic gastric mucosae , 2012, The Journal of pathology.

[6]  N. Uedo,et al.  Eradication of H. pylori Did Not Improve Abnormal Sonic Hedgehog Expression in the High Risk Group for Gastric Cancer , 2012, Digestive Diseases and Sciences.

[7]  C. González,et al.  Carcinogenesis, prevention and early detection of gastric cancer: Where we are and where we should go , 2012, International journal of cancer.

[8]  T. Ushijima,et al.  Identification of gastric cancer risk markers that are informative in individuals with past H. pylori infection , 2012, Gastric Cancer.

[9]  T. Ushijima,et al.  Molecular Pathways Molecular Pathways : Involvement of Helicobacter pylori – Triggered In fl ammation in the Formation of an Epigenetic Field Defect , and Its Usefulness as Cancer Risk and Exposure Markers , 2012 .

[10]  Peter A. Jones,et al.  A decade of exploring the cancer epigenome — biological and translational implications , 2011, Nature Reviews Cancer.

[11]  N. Watanabe,et al.  Revisit of Field Cancerization in Squamous Cell Carcinoma of Upper Aerodigestive Tract: Better Risk Assessment with Epigenetic Markers , 2011, Cancer Prevention Research.

[12]  M. Esteller,et al.  Cancer epigenetics reaches mainstream oncology , 2011, Nature Medicine.

[13]  Takeshi Toyoda,et al.  Inflammatory processes triggered by Helicobacter pylori infection cause aberrant DNA methylation in gastric epithelial cells. , 2010, Cancer research.

[14]  S. Hirohashi,et al.  Genome‐wide DNA methylation profiles in urothelial carcinomas and urothelia at the precancerous stage , 2010, Cancer science.

[15]  A. Bhattacharyya,et al.  A multicenter, double-blinded validation study of methylation biomarkers for progression prediction in Barrett's esophagus. , 2009, Cancer research.

[16]  M. Tatematsu,et al.  DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: Its possible involvement in the formation of epigenetic field defect , 2009, International journal of cancer.

[17]  M. Asaka,et al.  Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial , 2008, The Lancet.

[18]  C. Boland,et al.  Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma , 2008, Hepatology.

[19]  Mihaela Campan,et al.  DNA methylation profiles of gastric carcinoma characterized by quantitative DNA methylation analysis , 2008, Laboratory Investigation.

[20]  A. Andriulli,et al.  Aberrant DNA Methylation in Non-Neoplastic Gastric Mucosa of H. Pylori Infected Patients and Effect of Eradication , 2007, The American Journal of Gastroenterology.

[21]  T. Ushijima.  Epigenetic field for cancerization. , 2007, Journal of biochemistry and molecular biology.

[22]  Timothy J. Yeatman,et al.  Mapping Geographic Zones of Cancer Risk with Epigenetic Biomarkers in Normal Breast Tissue , 2006, Clinical Cancer Research.

[23]  T. Sugimura,et al.  Higher Methylation Levels in Gastric Mucosae Significantly Correlate with Higher Risk of Gastric Cancers , 2006, Cancer Epidemiology Biomarkers & Prevention.

[24]  T. Gotoda,et al.  Metachronous gastric cancers after endoscopic resection: how effective is annual endoscopic surveillance? , 2006, Gastric Cancer.

[25]  A. Kaneda,et al.  High Levels of Aberrant DNA Methylation in Helicobacter pylori–Infected Gastric Mucosae and its Possible Association with Gastric Cancer Risk , 2006, Clinical Cancer Research.

[26]  B. C. Wong,et al.  Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation , 2006, Gut.

[27]  M. Juhola,et al.  Evaluation of the diagnostic accuracy of gastroscopy to detect gastric tumours: clinicopathological features and prognosis of patients with gastric cancer missed on endoscopy , 2005, European journal of gastroenterology & hepatology.

[28]  Gary L Rosner,et al.  Tumour vasculature: On the verge of collapse , 2005, Nature Reviews Cancer.

[29]  A. Feinberg,et al.  Loss of IGF2 Imprinting: A Potential Marker of Colorectal Cancer Risk , 2003, Science.

[30]  N. Ahuja,et al.  Accelerated age-related CpG island methylation in ulcerative colitis. , 2001, Cancer research.

[31]  S. Hirohashi,et al.  Genetic instability and aberrant DNA methylation in chronic hepatitis and cirrhosis—A comprehensive study of loss of heterozygosity and microsatellite instability at 39 loci and DNA hypermethylation on 8 CpG islands in microdissected specimens from patients with hepatocellular carcinoma , 2000, Hepatology.

[32]  P. Laird,et al.  Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. , 2000, Cancer research.

[33]  O. Hosokawa,et al.  Diagnosis of Gastric Cancer up to Three Years after Negative Upper Gastrointestinal Endoscopy , 1998, Endoscopy.

[34]  C. Hsieh,et al.  Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. , 1998, Cancer research.

[35]  J. A. Bargen,et al.  Multiple gastric cancers; review of the literature and study of 42 cases. , 1957, Gastroenterology.

[36]  T. Moriyama,et al.  Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. , 2012, Gastrointestinal endoscopy.

[37]  M. Toyota,et al.  Aberrant Methylation of RASGRF 1 Is Associated with an Epigenetic Field Defect and IncreasedRisk of Gastric Cancer , 2012 .

[38]  T. Ushijima,et al.  Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication , 2009, Journal of Gastroenterology.